ReviewBiomedical physics & engineering express2026
Magnetic nanoparticles for cancer theranostics.
Review in Biomedical physics & engineering express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From Magnetic Moment to Magnetic Particle Imaging: A Comprehensive Review on MPI Technology, Tracer Design and Biological Applications.Pharmaceutics · 2026Review
- Engineering Multimodal Nanomaterials for Prostate Cancer Theranostics: Design Principles, Recent Advances, and Translational Challenges.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Magnetic nanoparticles (MNPs) have emerged as a powerful tool in cancer theranostics due to their unique size-dependent magnetic properties, surface functionalization capabilities, and responsiveness to external magnetic fields. This review outlines different types of MNPs, including those composed of pure metals, metal oxides, and metallic alloys, and highlights their size-dependent magnetic behavior, such as superparamagnetism and dynamic magnetizations. We also explore the critical role of surface modification strategies in enhancing MNPs' biocompatibility, colloidal stability, and functional versatility for targeted biomedical applications. The applications of MNPs in cancer therapy are discussed, with a focus on magnetic hyperthermia, drug and gene delivery, and a combination of various therapies. Additionally, we examine their cancer diagnostic roles in imaging techniques such as magnetic resonance imaging (MRI) and magnetic particle imaging (MPI), and emerging magnetic biosensing technologies such as giant magnetoresistance (GMR), magnetic tunnel junction (MTJ), magnetic particle spectroscopy (MPS), and nuclear magnetic resonance (NMR)-based platforms. These advances collectively establish MNPs as key components in the future of personalized cancer diagnosis and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.